NCT00749645View on ClinicalTrials.gov

Efficacy Study of FANG(30) for Active Rheumatoid Arthritis in Adult Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

January 31, 2008

Study Completion Date

February 29, 2008

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

FANG(30)

Andrographolide formula Oral tablets, 30mg, three times per day, during a total of 105 continuous days.

DRUG

Placebo

Placebo 30mg tabs, 3/day, 105 days continuously.

Trial Locations (2)

5090000

Hospital Clínico Regional, Valdivia

5290000

HOSPITAL REGIONAL de OSORNO, Osorno

All Listed Sponsors
collaborator

Fondo Nacional de Desarrollo Científico y Tecnológico, Chile

OTHER_GOV

lead

Juan C. Bertoglio, MD

OTHER

NCT00749645 - Efficacy Study of FANG(30) for Active Rheumatoid Arthritis in Adult Patients | Biotech Hunter | Biotech Hunter